The latest closing stock price for Checkpoint Therapeutics as of February 21, 2025 is 3.13.
An investor who bought $1,000 worth of Checkpoint Therapeutics stock at the IPO in 2017 would have $-969 today, roughly -1 times their original investment - a -35.15% compound annual growth rate over 8 years.
The all-time high Checkpoint Therapeutics stock closing price was 100.00 on June 26, 2017.
The Checkpoint Therapeutics 52-week high stock price is 4.50, which is 43.8% above the current share price.
The Checkpoint Therapeutics 52-week low stock price is 1.38, which is 55.9% below the current share price.
The average Checkpoint Therapeutics stock price for the last 52 weeks is 2.55.
An investor who bought $1,000 worth of Checkpoint Therapeutics stock at the IPO in 2017 would have $-969 today, roughly -1 times their original investment - a -35.15% compound annual growth rate over 8 years.
The all-time high Checkpoint Therapeutics stock closing price was 100.00 on June 26, 2017.
The Checkpoint Therapeutics 52-week high stock price is 4.50, which is 43.8% above the current share price.
The Checkpoint Therapeutics 52-week low stock price is 1.38, which is 55.9% below the current share price.
The average Checkpoint Therapeutics stock price for the last 52 weeks is 2.55.